Immunoglobulin G [EPC]

Immunoglobulin G [EPC] was reported 21060 times

Drugs of the Immunoglobulin G [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LUNG DISEASE INFECTIVE EXACERBATION 12 0.4444
1 PROTOTHECOSIS 30 0.3191
2 COMPLICATIONS OF TRANSPLANTED PANCREAS 8 0.2286
3 SLEEP-RELATED BREATHING DISORDER 8 0.2105
4 PYELONEPHRITIS FUNGAL 15 0.2027
5 DELAYED GRAFT FUNCTION 111 0.1561
6 DONOR SPECIFIC ANTIBODY PRESENT 24 0.1558
7 ENCEPHALITIS CYTOMEGALOVIRUS 68 0.1553
8 RETINOPATHY HAEMORRHAGIC 10 0.1515
9 AUTOIMMUNE PANCYTOPENIA 13 0.1429
10 ANORECTAL VARICES 6 0.1429
11 ENGRAFT FAILURE 40 0.1394
12 PERINEPHRIC ABSCESS 21 0.1382
13 RENAL GRAFT LOSS 11 0.1358
14 CHIMERISM 12 0.1348
15 HYPERFIBRINOGENAEMIA 9 0.1343
16 HEART TRANSPLANT REJECTION 139 0.1339
17 GRAFT LOSS 97 0.1338
18 GRAFT VERSUS HOST DISEASE IN INTESTINE 16 0.1231
19 SKIN GRAFT REJECTION 7 0.1228
20 ISOSPORIASIS 9 0.1154
21 PANCREAS TRANSPLANT REJECTION 23 0.1144
22 SEPTAL PANNICULITIS 9 0.1125
23 NEW ONSET DIABETES AFTER TRANSPLANTATION 18 0.1040
24 PHARYNGEAL POLYP 9 0.1023
25 CYTOMEGALOVIRUS DUODENITIS 7 0.1000
26 POLYOMAVIRUS VIRAEMIA 101 0.0951
27 EPSTEIN-BARR VIRAEMIA 104 0.0938
28 ADENOVIRAL HEPATITIS 22 0.0936
29 EMPHYSEMATOUS PYELONEPHRITIS 17 0.0929
30 SERUM SICKNESS 251 0.0900
31 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 234 0.0846
32 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 119 0.0842
33 METAPNEUMOVIRUS PNEUMONIA 8 0.0833
34 RENAL GRAFT INFECTION 19 0.0819
35 CHRONIC ALLOGRAFT NEPHROPATHY 64 0.0817
36 AEROMONAS INFECTION 15 0.0794
37 GRAFT DYSFUNCTION 22 0.0772
38 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 54 0.0751
39 ANGIOSARCOMA METASTATIC 9 0.0738
40 BK POLYOMAVIRUS TEST POSITIVE 7 0.0729
41 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 123 0.0695
42 URINARY TRACT CANDIDIASIS 13 0.0681
43 BK VIRUS INFECTION 229 0.0678
44 COMPLICATIONS OF TRANSPLANTED KIDNEY 148 0.0652
45 CYTOMEGALOVIRUS TEST POSITIVE 116 0.0650
46 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 19 0.0638
47 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 149 0.0635
48 COLITIS EROSIVE 10 0.0629
49 ENTEROCOLITIS VIRAL 19 0.0625
50 HEPATITIS INFECTIOUS MONONUCLEOSIS 6 0.0619
51 TRANSPLANT REJECTION 494 0.0616
52 PARVOVIRUS B19 INFECTION 55 0.0615
53 GENITAL HERPES SIMPLEX 13 0.0613
54 MUCOSAL HYPERTROPHY 9 0.0608
55 ACUTE GRAFT VERSUS HOST DISEASE 268 0.0585
56 URINOMA 9 0.0570
57 INTRACRANIAL INFECTION 7 0.0560
58 CYTOMEGALOVIRUS GASTROENTERITIS 12 0.0556
59 POST TRANSPLANT DISTAL LIMB SYNDROME 11 0.0542
60 RENAL TRANSPLANT FAILURE 53 0.0536
61 LATENT AUTOIMMUNE DIABETES IN ADULTS 9 0.0526
62 ACUTE MYELOID LEUKAEMIA RECURRENT 112 0.0521
63 VIRAL HAEMORRHAGIC CYSTITIS 37 0.0520
64 TOOTH HYPOPLASIA 9 0.0517
65 BRONCHIOLITIS OBLITERANS SYNDROME 9 0.0514
66 CHRONIC GRAFT VERSUS HOST DISEASE 183 0.0506
67 COMPLICATIONS OF BONE MARROW TRANSPLANT 18 0.0499
68 ACUTE CHOLECYSTITIS NECROTIC 10 0.0498
69 GRAFT THROMBOSIS 13 0.0496
70 WEST NILE VIRAL INFECTION 37 0.0493
71 CYTOMEGALOVIRUS INFECTION REACTIVATION 217 0.0491
72 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 7 0.0490
73 ASPERGILLUS TEST POSITIVE 15 0.0487
74 ADENOVIRUS REACTIVATION 7 0.0486
75 RETICULOCYTOPENIA 7 0.0479
76 KIDNEY TRANSPLANT REJECTION 228 0.0475
77 IDIOPATHIC PNEUMONIA SYNDROME 14 0.0470
78 BLOOD STEM CELL TRANSPLANT FAILURE 10 0.0465
79 DISSEMINATED CYTOMEGALOVIRAL INFECTION 10 0.0463
80 CRYPTOCOCCAL MENINGOENCEPHALITIS 6 0.0458
81 PARVOVIRUS INFECTION 18 0.0446
82 CYTOMEGALOVIRUS VIRAEMIA 196 0.0440
83 ENGRAFTMENT SYNDROME 26 0.0440
84 TRANSPLANT FAILURE 107 0.0436
85 PULMONARY MUCORMYCOSIS 23 0.0436
86 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 218 0.0428
87 CYTOMEGALOVIRUS OESOPHAGITIS 15 0.0408
88 PNEUMONIA CYTOMEGALOVIRAL 77 0.0396
89 EPSTEIN-BARR VIRUS INFECTION 246 0.0393
90 CENTRAL HYPOTHYROIDISM 13 0.0393
91 ADENOVIRUS INFECTION 113 0.0389
92 RENAL ARTERY THROMBOSIS 12 0.0388
93 TRANSPLANT DYSFUNCTION 69 0.0386
94 KLEBSIELLA URINARY TRACT INFECTION 10 0.0377
95 COMPLICATIONS OF TRANSPLANT SURGERY 19 0.0376
96 SPLENIC ABSCESS 15 0.0369
97 SCEDOSPORIUM INFECTION 26 0.0368
98 CYSTITIS HAEMORRHAGIC 148 0.0367
99 CYTOMEGALOVIRUS ENTERITIS 13 0.0365
100 CYTOMEGALOVIRUS SYNDROME 6 0.0364
101 EYE INFECTION TOXOPLASMAL 14 0.0353
102 ENAMEL ANOMALY 10 0.0350
103 SCROTAL ULCER 9 0.0345
104 RENAL CORTICAL NECROSIS 8 0.0343
105 GRAFT VERSUS HOST DISEASE 247 0.0343
106 MICROSPORIDIA INFECTION 12 0.0342
107 TRICHODYSPLASIA SPINULOSA 13 0.0341
108 CYSTITIS VIRAL 13 0.0339
109 CERVICITIS 15 0.0336
110 GRAFT VERSUS HOST DISEASE IN SKIN 74 0.0336
111 LYMPHOCELE 22 0.0331
112 CUTANEOUS TUBERCULOSIS 6 0.0330
113 ANAEMIA HAEMOLYTIC AUTOIMMUNE 27 0.0326
114 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0316
115 CANDIDA SEPSIS 28 0.0312
116 RED BLOOD CELL SCHISTOCYTES PRESENT 10 0.0309
117 GRAFT VERSUS HOST DISEASE IN LIVER 22 0.0307
118 MORGANELLA INFECTION 9 0.0307
119 RENAL TUBULAR ATROPHY 27 0.0306
120 MALACOPLAKIA 14 0.0306
121 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 7 0.0302
122 CEREBRAL TOXOPLASMOSIS 28 0.0300
123 VESICOURETERIC REFLUX 12 0.0296
124 CYTOMEGALOVIRUS INFECTION 484 0.0291
125 CAPILLARITIS 8 0.0290
126 INFECTION REACTIVATION 33 0.0288
127 ENTEROCOCCAL SEPSIS 23 0.0284
128 CITROBACTER INFECTION 12 0.0280
129 ENCEPHALITIS VIRAL 34 0.0279
130 COMPLICATIONS OF TRANSPLANTED HEART 6 0.0279
131 HUMAN HERPESVIRUS 6 INFECTION 52 0.0275
132 VENOOCCLUSIVE DISEASE 67 0.0267
133 SYSTEMIC CANDIDA 67 0.0267
134 AMERICAN TRYPANOSOMIASIS 7 0.0259
135 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 12 0.0257
136 CORONA VIRUS INFECTION 11 0.0256
137 DISSEMINATED MUCORMYCOSIS 10 0.0254
138 BURKHOLDERIA CEPACIA COMPLEX INFECTION 7 0.0245
139 LIVER TRANSPLANT REJECTION 43 0.0239
140 VIRAEMIA 33 0.0238
141 THROMBOTIC MICROANGIOPATHY 227 0.0233
142 TOXOPLASMOSIS 25 0.0231
143 MUCORMYCOSIS 60 0.0231
144 LUNG TRANSPLANT REJECTION 15 0.0227
145 HAEMOSIDEROSIS 6 0.0224
146 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 47 0.0221
147 ANTITHROMBIN III DECREASED 6 0.0220
148 ASPERGILLOSIS 28 0.0214
149 ZYGOMYCOSIS 10 0.0214
150 BACTERIURIA 12 0.0212
151 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 11 0.0210
152 ARTHRITIS REACTIVE 13 0.0208
153 CYTOMEGALOVIRUS ENTEROCOLITIS 16 0.0208
154 PNEUMONIA ESCHERICHIA 7 0.0206
155 BLASTOMYCOSIS 10 0.0206
156 T-LYMPHOCYTE COUNT DECREASED 14 0.0205
157 GINGIVAL HYPERTROPHY 31 0.0204
158 VIRAL DIARRHOEA 7 0.0203
159 EXTRAPULMONARY TUBERCULOSIS 6 0.0203
160 HAEMOLYTIC URAEMIC SYNDROME 47 0.0203
161 NEUTROPHILIC DERMATOSIS 8 0.0203
162 MENINGOENCEPHALITIS HERPETIC 9 0.0201
163 PSEUDOMONAL SEPSIS 35 0.0200
164 KIDNEY FIBROSIS 34 0.0196
165 COMPLICATIONS OF TRANSPLANTED LIVER 7 0.0194
166 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 18 0.0194
167 APOPTOSIS 6 0.0194
168 URINARY TRACT INFECTION ENTEROCOCCAL 18 0.0193
169 EPSTEIN-BARR VIRUS TEST POSITIVE 12 0.0190
170 VENOOCCLUSIVE LIVER DISEASE 94 0.0190
171 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 25 0.0190
172 HAPTOGLOBIN DECREASED 15 0.0186
173 MEASLES 10 0.0186
174 URINARY TRACT INFECTION PSEUDOMONAL 11 0.0183
175 INFECTIVE ANEURYSM 9 0.0182
176 RENAL TUBULAR INJURY 22 0.0181
177 PROTEUS INFECTION 13 0.0181
178 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 29 0.0181
179 OPERATIVE HAEMORRHAGE 8 0.0179
180 HISTIOCYTOSIS HAEMATOPHAGIC 53 0.0178
181 BRONCHOPULMONARY ASPERGILLOSIS 138 0.0178
182 CRYPTOCOCCOSIS 29 0.0178
183 BRAIN ABSCESS 45 0.0178
184 KLEBSIELLA SEPSIS 20 0.0177
185 KLEBSIELLA INFECTION 89 0.0176
186 HEPATITIS C RNA INCREASED 6 0.0175
187 STEM CELL TRANSPLANT 43 0.0172
188 CRYPTOSPORIDIOSIS INFECTION 9 0.0171
189 LICHENIFICATION 7 0.0170
190 HEPATITIS C VIRUS TEST POSITIVE 10 0.0170
191 CYTOMEGALOVIRUS COLITIS 39 0.0169
192 CAPILLARY LEAK SYNDROME 35 0.0169
193 CYTOMEGALOVIRUS CHORIORETINITIS 33 0.0169
194 COAGULATION TEST ABNORMAL 13 0.0169
195 SMOOTH MUSCLE CELL NEOPLASM 7 0.0167
196 PNEUMOCYSTIS JIROVECII INFECTION 20 0.0167
197 TRANSPLANTATION COMPLICATION 7 0.0167
198 GASTROENTERITIS ESCHERICHIA COLI 9 0.0165
199 PARAINFLUENZAE VIRUS INFECTION 25 0.0164
200 NEUROENDOCRINE CARCINOMA OF THE SKIN 16 0.0163
201 ENCEPHALITIS HERPES 8 0.0162
202 ENTEROCOCCAL INFECTION 78 0.0161
203 GLOMERULOSCLEROSIS 10 0.0158
204 PULMONARY NOCARDIOSIS 13 0.0158
205 HERPES SIMPLEX REACTIVATION 6 0.0157
206 ABDOMINAL WALL ABSCESS 10 0.0154
207 CALCIUM DEFICIENCY 20 0.0154
208 CAMPYLOBACTER GASTROENTERITIS 9 0.0152
209 APLASTIC ANAEMIA 79 0.0151
210 ENTEROCOCCAL BACTERAEMIA 16 0.0151
211 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 7 0.0149
212 NOCARDIOSIS 38 0.0148
213 STRONGYLOIDIASIS 24 0.0148
214 HUMAN HERPESVIRUS 8 INFECTION 9 0.0148
215 KLEBSIELLA BACTERAEMIA 14 0.0147
216 GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0146
217 RENAL ISCHAEMIA 8 0.0146
218 STAPHYLOCOCCAL SEPSIS 72 0.0146
219 CANDIDA TEST POSITIVE 6 0.0144
220 APLASIA PURE RED CELL 49 0.0142
221 EVANS SYNDROME 7 0.0142
222 CHORIORETINITIS 9 0.0140
223 STAPHYLOCOCCAL BACTERAEMIA 60 0.0138
224 ACINETOBACTER INFECTION 15 0.0137
225 METASTATIC SQUAMOUS CELL CARCINOMA 7 0.0137
226 SYSTEMIC MYCOSIS 16 0.0137
227 ENTEROBACTER INFECTION 23 0.0137
228 RENAL TUBULAR NECROSIS 134 0.0136
229 RENAL HAEMATOMA 7 0.0136
230 LYMPHOPROLIFERATIVE DISORDER 39 0.0133
231 CAMPYLOBACTER INFECTION 11 0.0132
232 RENAL ARTERY STENOSIS 18 0.0131
233 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 43 0.0130
234 PROCEDURAL HYPOTENSION 11 0.0129
235 LUNG INFECTION PSEUDOMONAL 7 0.0125
236 INFECTION IN AN IMMUNOCOMPROMISED HOST 9 0.0125
237 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 15 0.0125
238 RETICULOCYTE COUNT INCREASED 10 0.0124
239 BACTERIAL SEPSIS 40 0.0123
240 OBLITERATIVE BRONCHIOLITIS 16 0.0122
241 ENDOCARDITIS STAPHYLOCOCCAL 6 0.0122
242 SEPTIC EMBOLUS 10 0.0120
243 GRAFT COMPLICATION 7 0.0119
244 ESCHERICHIA BACTERAEMIA 28 0.0119
245 GLOMERULONEPHRITIS 29 0.0118
246 HYPERTENSIVE ENCEPHALOPATHY 7 0.0118
247 CENTRAL SEROUS CHORIORETINOPATHY 8 0.0117
248 SKIN TOXICITY 66 0.0117
249 MENINGITIS CRYPTOCOCCAL 20 0.0114
250 ESCHERICHIA SEPSIS 33 0.0114
251 MUSCLE ABSCESS 7 0.0112
252 MUCOUS MEMBRANE DISORDER 15 0.0110
253 HEPATOSPLENOMEGALY 28 0.0109
254 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 28 0.0108
255 FUNGAL SEPSIS 9 0.0108
256 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 10 0.0108
257 TRANSITIONAL CELL CARCINOMA 14 0.0108
258 BACTERAEMIA 127 0.0107
259 ASPERGILLUS INFECTION 69 0.0105
260 HERPES SIMPLEX 68 0.0105
261 ESCHERICHIA INFECTION 85 0.0103
262 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 8 0.0102
263 HAEMATOLOGICAL INFECTION 25 0.0102
264 IRON OVERLOAD 11 0.0102
265 HYPERTENSIVE EMERGENCY 12 0.0102
266 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 8 0.0102
267 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 6 0.0102
268 HISTOPLASMOSIS DISSEMINATED 16 0.0101
269 FUSARIUM INFECTION 7 0.0100
270 CLOSTRIDIUM COLITIS 12 0.0099
271 GASTROENTERITIS NOROVIRUS 13 0.0098
272 SKIN TEST POSITIVE 9 0.0096
273 URINARY TRACT INFECTION BACTERIAL 24 0.0095
274 NEUTROPENIC INFECTION 9 0.0094
275 PNEUMONIA INFLUENZAL 11 0.0092
276 NON-HODGKIN'S LYMPHOMA 12 0.0092
277 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 87 0.0091
278 NEPHROPATHY TOXIC 102 0.0091
279 MULTI-ORGAN FAILURE 157 0.0091
280 DRUG LEVEL FLUCTUATING 8 0.0090
281 LYMPHOCYTIC INFILTRATION 9 0.0089
282 METAPNEUMOVIRUS INFECTION 7 0.0089
283 NORMOCYTIC ANAEMIA 13 0.0088
284 URETERIC STENOSIS 7 0.0087
285 PNEUMOCYSTIS JIROVECI PNEUMONIA 19 0.0085
286 GLOMERULONEPHRITIS MEMBRANOUS 10 0.0085
287 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 63 0.0084
288 ORCHITIS 9 0.0084
289 PNEUMONIA FUNGAL 33 0.0084
290 NOROVIRUS INFECTION 12 0.0083
291 PYELONEPHRITIS ACUTE 16 0.0082
292 STENOTROPHOMONAS INFECTION 11 0.0081
293 PNEUMONIA STAPHYLOCOCCAL 16 0.0081
294 PYURIA 8 0.0081
295 HYPOGAMMAGLOBULINAEMIA 51 0.0078
296 GENERALISED OEDEMA 94 0.0076
297 ELECTROMECHANICAL DISSOCIATION 6 0.0075
298 DIFFUSE LARGE B-CELL LYMPHOMA 56 0.0073
299 BONE MARROW DEPRESSION 7 0.0072
300 H1N1 INFLUENZA 10 0.0071
301 PSEUDOMONAS INFECTION 61 0.0071
302 CYTOLYTIC HEPATITIS 23 0.0069
303 RENAL INFARCT 10 0.0069
304 HYPOCHROMIC ANAEMIA 7 0.0069
305 RESPIRATORY TRACT INFECTION VIRAL 16 0.0069
306 CARDIOACTIVE DRUG LEVEL INCREASED 9 0.0068
307 ESCHERICHIA URINARY TRACT INFECTION 29 0.0068
308 BLOOD ALBUMIN INCREASED 6 0.0067
309 MICROCYTIC ANAEMIA 14 0.0067
310 VARICELLA 16 0.0067
311 GASTROINTESTINAL WALL THICKENING 10 0.0067
312 DISSEMINATED TUBERCULOSIS 17 0.0066
313 PNEUMOCYSTIS JIROVECII PNEUMONIA 66 0.0066
314 PNEUMONIA KLEBSIELLA 12 0.0065
315 METASTATIC MALIGNANT MELANOMA 15 0.0065
316 LARGE INTESTINE INFECTION 8 0.0065
317 ACUTE RESPIRATORY DISTRESS SYNDROME 115 0.0065
318 HAEMOCHROMATOSIS 6 0.0065
319 OLIGURIA 40 0.0064
320 STREPTOCOCCAL BACTERAEMIA 7 0.0064
321 HYDRONEPHROSIS 48 0.0064
322 TINEA INFECTION 7 0.0063
323 NEPHRITIS INTERSTITIAL 8 0.0063
324 CONTINUOUS HAEMODIAFILTRATION 6 0.0061
325 APLASIA 12 0.0061
326 CANDIDIASIS 24 0.0060
327 LYMPHOPENIA 84 0.0059
328 SALMONELLOSIS 10 0.0059
329 NEPHROCALCINOSIS 7 0.0059
330 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
331 ISCHAEMIC HEPATITIS 8 0.0058
332 HAEMOLYTIC ANAEMIA 52 0.0058
333 MULTIPLE ORGAN DYSFUNCTION SYNDROME 158 0.0056
334 BACTERIAL INFECTION 103 0.0055
335 CANDIDA INFECTION 93 0.0055
336 SERUM FERRITIN INCREASED 29 0.0055
337 CERVICAL DYSPLASIA 12 0.0055
338 ANTIBODY TEST POSITIVE 9 0.0054
339 FEBRILE NEUTROPENIA 357 0.0054
340 PSEUDOMEMBRANOUS COLITIS 12 0.0054
341 LEUKAEMIA RECURRENT 9 0.0053
342 BONE MARROW FAILURE 108 0.0053
343 VARICELLA ZOSTER VIRUS INFECTION 11 0.0053
344 SHOCK HAEMORRHAGIC 43 0.0053
345 RENAL TRANSPLANT 19 0.0053
346 HAEMODIALYSIS 44 0.0052
347 PNEUMONIA PSEUDOMONAL 8 0.0052
348 CLOSTRIDIUM DIFFICILE COLITIS 55 0.0052
349 DISSEMINATED INTRAVASCULAR COAGULATION 73 0.0052
350 BICYTOPENIA 10 0.0051
351 PYELONEPHRITIS 44 0.0051
352 HEPATITIS E 8 0.0051
353 IDIOPATHIC THROMBOCYTOPENIC PURPURA 8 0.0051
354 CELL DEATH 10 0.0050
355 PNEUMONIA VIRAL 16 0.0050
356 ANURIA 43 0.0050
357 PULMONARY HAEMORRHAGE 39 0.0050
358 HAEMOLYSIS 38 0.0049
359 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
360 RHINOVIRUS INFECTION 19 0.0049
361 SEPTIC SHOCK 210 0.0048
362 SMALL INTESTINAL PERFORATION 9 0.0048
363 TONSILLAR HYPERTROPHY 8 0.0048
364 BONE MARROW TRANSPLANT 9 0.0047
365 RESPIRATORY DISTRESS 131 0.0047
366 PANCYTOPENIA 265 0.0047
367 NEPHRECTOMY 7 0.0047
368 BLOOD CULTURE POSITIVE 14 0.0047
369 ARTERIAL THROMBOSIS 9 0.0047
370 LUNG CONSOLIDATION 13 0.0046
371 HYPOALBUMINAEMIA 36 0.0046
372 FUNGAL PERITONITIS 7 0.0046
373 PARESIS 10 0.0045
374 PULMONARY ALVEOLAR HAEMORRHAGE 25 0.0045
375 FUNGAEMIA 7 0.0044
376 MUCOSAL INFLAMMATION 116 0.0044
377 RENAL HAEMORRHAGE 9 0.0044
378 PATHOGEN RESISTANCE 40 0.0044
379 SUBCUTANEOUS ABSCESS 21 0.0044
380 JC VIRUS INFECTION 7 0.0044
381 LEUKOPENIA 215 0.0043
382 ENDOCARDITIS 22 0.0043
383 PNEUMONIA BACTERIAL 39 0.0042
384 HEPATIC NECROSIS 16 0.0042
385 PAPILLOMA VIRAL INFECTION 7 0.0042
386 HYPOPROTEINAEMIA 8 0.0042
387 HAEMODYNAMIC INSTABILITY 32 0.0042
388 NEPHRITIS 14 0.0042
389 MYELODYSPLASTIC SYNDROME 60 0.0041
390 ACUTE PULMONARY OEDEMA 23 0.0041
391 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 10 0.0040
392 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 20 0.0040
393 GASTROINTESTINAL OEDEMA 7 0.0040
394 HISTOPLASMOSIS 7 0.0040
395 BLOOD BILIRUBIN INCREASED 106 0.0039
396 ENCEPHALITIS 27 0.0039
397 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
398 NEUTROPENIC COLITIS 8 0.0039
399 BLOOD LACTATE DEHYDROGENASE INCREASED 61 0.0038
400 CLOSTRIDIAL INFECTION 13 0.0038
401 GRANULOMA 13 0.0038
402 CD4 LYMPHOCYTES DECREASED 8 0.0037
403 IMMUNE THROMBOCYTOPENIA 17 0.0037
404 METASTATIC NEOPLASM 16 0.0037
405 ERYTHEMA NODOSUM 13 0.0037
406 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
407 INFUSION SITE REACTION 11 0.0037
408 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
409 URINE OUTPUT DECREASED 32 0.0037
410 ORAL FUNGAL INFECTION 10 0.0036
411 HEPATITIS B 22 0.0036
412 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
413 VENTRICULAR HYPERTROPHY 9 0.0036
414 RENAL TUBULAR DISORDER 10 0.0036
415 MYELOSUPPRESSION 128 0.0036
416 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 7 0.0035
417 PNEUMATOSIS INTESTINALIS 10 0.0035
418 HEPATIC FIBROSIS 12 0.0035
419 HYPERBILIRUBINAEMIA 36 0.0035
420 ACUTE MYELOID LEUKAEMIA 54 0.0035
421 HYPERURICAEMIA 14 0.0034
422 BLOOD CREATININE INCREASED 222 0.0034
423 NEPHROTIC SYNDROME 23 0.0034
424 GUILLAIN-BARRE SYNDROME 16 0.0033
425 CYTOKINE RELEASE SYNDROME 66 0.0033
426 UROSEPSIS 30 0.0032
427 LYMPHADENOPATHY 115 0.0032
428 B-CELL LYMPHOMA 11 0.0032
429 ORGANISING PNEUMONIA 16 0.0032
430 PROTEINURIA 61 0.0032
431 PERICARDIAL HAEMORRHAGE 7 0.0032
432 ENTEROCOLITIS 18 0.0031
433 LYMPHOCYTE COUNT INCREASED 10 0.0031
434 NEUROLOGICAL DECOMPENSATION 7 0.0030
435 TACHYPNOEA 41 0.0030
436 AZOTAEMIA 12 0.0030
437 STAPHYLOCOCCAL INFECTION 99 0.0030
438 OVARIAN CYST 30 0.0030
439 HYPERLACTACIDAEMIA 8 0.0030
440 CORONARY ARTERY THROMBOSIS 6 0.0030
441 LARGE INTESTINAL ULCER 8 0.0029
442 CARDIAC TAMPONADE 14 0.0029
443 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 19 0.0029
444 FIBROSIS 9 0.0029
445 BRAIN DEATH 9 0.0029
446 LYMPHADENITIS 7 0.0029
447 SEPSIS 319 0.0029
448 HYPERPYREXIA 12 0.0028
449 TACHYARRHYTHMIA 7 0.0028
450 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
451 STUPOR 9 0.0028
452 RESPIRATORY FAILURE 203 0.0028
453 CYTOPENIA 34 0.0028
454 LIVER ABSCESS 9 0.0028
455 LIVER FUNCTION TEST ABNORMAL 80 0.0027
456 HYPERTHERMIA 21 0.0027
457 GASTROINTESTINAL NECROSIS 8 0.0027
458 RENAL IMPAIRMENT 230 0.0027
459 THROMBOCYTOPENIA 303 0.0027
460 NO THERAPEUTIC RESPONSE 33 0.0027
461 ACUTE RESPIRATORY FAILURE 52 0.0027
462 SKIN NECROSIS 14 0.0027
463 CREPITATIONS 8 0.0027
464 WOUND DEHISCENCE 9 0.0027
465 PULMONARY OEDEMA 119 0.0027
466 COAGULOPATHY 44 0.0026
467 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
468 DENGUE FEVER 6 0.0026
469 CHEST X-RAY ABNORMAL 8 0.0026
470 HERPES VIRUS INFECTION 15 0.0026
471 AUTOIMMUNE HEPATITIS 18 0.0026
472 INTESTINAL ISCHAEMIA 14 0.0025
473 HEPATITIS B REACTIVATION 8 0.0025
474 HYPERKALAEMIA 87 0.0025
475 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
476 SUSPECTED OFF LABEL USE 11 0.0024
477 RENAL FAILURE ACUTE 102 0.0024
478 STRIDOR 7 0.0024
479 PERICARDIAL EFFUSION 55 0.0024
480 METASTASES TO LYMPH NODES 16 0.0024
481 FEBRILE BONE MARROW APLASIA 10 0.0024
482 PULMONARY TUBERCULOSIS 10 0.0023
483 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
484 BRONCHOPNEUMONIA 8 0.0023
485 SQUAMOUS CELL CARCINOMA OF SKIN 14 0.0023
486 ASCITES 68 0.0023
487 PYREXIA 798 0.0023
488 DRUG RESISTANCE 59 0.0023
489 DRUG LEVEL INCREASED 38 0.0023
490 TRANSAMINASES INCREASED 51 0.0023
491 HEPATOTOXICITY 51 0.0023
492 FLUID OVERLOAD 33 0.0023
493 LUNG INFILTRATION 20 0.0023
494 SHOCK 52 0.0023
495 DIALYSIS 32 0.0023
496 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
497 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
498 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
499 RALES 13 0.0022
500 SQUAMOUS CELL CARCINOMA 21 0.0022
501 FUNGAL SKIN INFECTION 9 0.0022
502 ACIDOSIS 17 0.0022
503 LUNG DISORDER 108 0.0022
504 HYPERAMMONAEMIA 11 0.0022
505 ACUTE HEPATIC FAILURE 30 0.0022
506 CORONARY ARTERY STENOSIS 11 0.0022
507 CHOLESTASIS 42 0.0022
508 TOXIC ENCEPHALOPATHY 11 0.0022
509 GASTROINTESTINAL INFLAMMATION 17 0.0022
510 DISEASE RECURRENCE 103 0.0022
511 LARGE INTESTINE PERFORATION 15 0.0022
512 HYPOXIA 76 0.0022
513 HYPOMAGNESAEMIA 30 0.0022
514 HEPATITIS C 26 0.0022
515 ACUTE KIDNEY INJURY 326 0.0021
516 LUNG INFECTION 33 0.0021
517 ENCEPHALOPATHY 52 0.0021
518 TONSILLITIS 11 0.0021
519 LYMPHOCYTE COUNT DECREASED 37 0.0021
520 VISUAL FIELD DEFECT 15 0.0021
521 AUTOIMMUNE DISORDER 20 0.0020
522 OESOPHAGEAL CANDIDIASIS 8 0.0020
523 CEREBRAL ATROPHY 8 0.0020
524 HEPATITIS ACUTE 13 0.0020
525 ORAL HERPES 39 0.0020
526 SKIN PAPILLOMA 8 0.0020
527 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
528 HEPATIC FUNCTION ABNORMAL 74 0.0020
529 PULMONARY TOXICITY 14 0.0020
530 BRAIN OEDEMA 25 0.0020
531 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
532 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
533 DRUG LEVEL DECREASED 20 0.0020
534 ANGIOPATHY 11 0.0020
535 DUODENITIS 6 0.0020
536 FUNGAL INFECTION 65 0.0019
537 SKIN MASS 13 0.0019
538 CACHEXIA 10 0.0019
539 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
540 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
541 PERITONITIS 40 0.0019
542 IMMUNOSUPPRESSION 17 0.0019
543 NEUROLOGICAL SYMPTOM 11 0.0019
544 PRE-ECLAMPSIA 9 0.0019
545 PULSE ABSENT 9 0.0019
546 ALANINE AMINOTRANSFERASE INCREASED 116 0.0019
547 ATRIAL FLUTTER 15 0.0019
548 CIRCULATORY COLLAPSE 32 0.0019
549 POST PROCEDURAL COMPLICATION 36 0.0019
550 FOOD POISONING 10 0.0019
551 COVID-19 PNEUMONIA 22 0.0019
552 HYPERCALCAEMIA 23 0.0019
553 PLEURISY 11 0.0019
554 HEPATIC LESION 8 0.0018
555 ODYNOPHAGIA 11 0.0018
556 HEPATOMEGALY 18 0.0018
557 HYPERVOLAEMIA 9 0.0018
558 NEUTROPENIA 247 0.0018
559 CEREBRAL HAEMORRHAGE 65 0.0018
560 DERMATITIS ACNEIFORM 11 0.0018
561 VIRAL LOAD INCREASED 7 0.0018
562 VASCULITIS 21 0.0018
563 HEPATOCELLULAR INJURY 25 0.0018
564 CHOLECYSTITIS 21 0.0018
565 DEVICE RELATED INFECTION 27 0.0018
566 WOUND INFECTION 19 0.0017
567 FAILURE TO THRIVE 9 0.0017
568 PLATELET COUNT DECREASED 183 0.0017
569 VENTRICULAR FIBRILLATION 19 0.0017
570 RASH MACULO-PAPULAR 38 0.0017
571 EXTRAVASATION 7 0.0017
572 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
573 DRUG SPECIFIC ANTIBODY PRESENT 11 0.0017
574 NEUTROPENIC SEPSIS 12 0.0017
575 INFUSION RELATED REACTION 110 0.0017
576 ATELECTASIS 16 0.0017
577 BLOOD PRESSURE DIASTOLIC DECREASED 12 0.0016
578 HEPATIC FAILURE 49 0.0016
579 GRAND MAL CONVULSION 15 0.0016
580 ABDOMINAL TENDERNESS 8 0.0016
581 LEUKOCYTOSIS 29 0.0016
582 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
583 HAEMATOTOXICITY 15 0.0016
584 RESPIRATORY RATE INCREASED 14 0.0016
585 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
586 VENTRICULAR TACHYCARDIA 26 0.0016
587 PHLEBITIS 8 0.0016
588 LIVER DISORDER 69 0.0016
589 PETECHIAE 16 0.0015
590 TACHYCARDIA 135 0.0015
591 MENTAL STATUS CHANGES 42 0.0015
592 CLOSTRIDIUM DIFFICILE INFECTION 33 0.0015
593 MULTIPLE MYELOMA 7 0.0015
594 MOUTH HAEMORRHAGE 11 0.0015
595 DIARRHOEA HAEMORRHAGIC 14 0.0015
596 INFECTION 215 0.0015
597 DRUG TOXICITY 20 0.0015
598 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 80 0.0015
599 C-REACTIVE PROTEIN INCREASED 53 0.0015
600 CHOLANGITIS 9 0.0015
601 HAEMORRHAGIC STROKE 11 0.0014
602 RETINAL HAEMORRHAGE 10 0.0014
603 HYPOTENSION 280 0.0014
604 BRADYCARDIA 74 0.0014
605 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
606 BLOOD UREA INCREASED 23 0.0014
607 THERAPY NON-RESPONDER 61 0.0014
608 BLOOD CREATINE INCREASED 6 0.0014
609 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
610 HYPOPHOSPHATAEMIA 10 0.0014
611 CARDIAC FAILURE ACUTE 9 0.0013
612 SKIN LESION 37 0.0013
613 CHILLS 158 0.0013
614 HAEMORRHAGE INTRACRANIAL 20 0.0013
615 PRODUCT USE IN UNAPPROVED INDICATION 329 0.0013
616 CARDIOGENIC SHOCK 19 0.0013
617 HYPERGLYCAEMIA 48 0.0013
618 THERAPEUTIC RESPONSE DECREASED 79 0.0013
619 RENAL FAILURE 173 0.0013
620 HEMIPARESIS 22 0.0013
621 HYPERTRANSAMINASAEMIA 9 0.0013
622 PNEUMONITIS 35 0.0013
623 PLEURAL EFFUSION 78 0.0013
624 MOUTH ULCERATION 27 0.0013
625 OEDEMA 69 0.0013
626 LEUKAEMIA 12 0.0013
627 DIVERTICULUM 9 0.0013
628 HAEMOGLOBIN DECREASED 130 0.0013
629 STEVENS-JOHNSON SYNDROME 28 0.0013
630 NECROSIS 7 0.0013
631 HEPATIC CYTOLYSIS 16 0.0013
632 INTESTINAL PERFORATION 14 0.0012
633 FISTULA 14 0.0012
634 OXYGEN SATURATION DECREASED 69 0.0012
635 ORAL DISORDER 9 0.0012
636 NEUTROPHIL COUNT DECREASED 50 0.0012
637 HAEMATOCRIT DECREASED 24 0.0012
638 CORONAVIRUS INFECTION 8 0.0012
639 ILEUS 15 0.0012
640 END STAGE RENAL DISEASE 22 0.0012
641 ANAPHYLACTIC SHOCK 31 0.0012
642 SPLENOMEGALY 14 0.0012
643 METABOLIC ACIDOSIS 38 0.0012
644 CARDIAC ARREST 98 0.0012
645 POSTOPERATIVE WOUND INFECTION 8 0.0012
646 SUBARACHNOID HAEMORRHAGE 12 0.0012
647 PROTHROMBIN TIME PROLONGED 7 0.0012
648 HAEMATURIA 40 0.0012
649 WHITE BLOOD CELL COUNT DECREASED 126 0.0012
650 TYPE 1 DIABETES MELLITUS 7 0.0012
651 PANCREATITIS ACUTE 26 0.0012
652 LARGE INTESTINE POLYP 8 0.0012
653 TENDERNESS 12 0.0012
654 CEREBRAL INFARCTION 28 0.0011
655 MYOCARDIAL ISCHAEMIA 13 0.0011
656 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
657 INFUSION SITE EXTRAVASATION 7 0.0011
658 STOMATITIS 68 0.0011
659 GINGIVITIS 6 0.0011
660 TREATMENT FAILURE 91 0.0011
661 HYPERTENSION 230 0.0011
662 URINARY TRACT INFECTION 183 0.0011
663 APPENDICITIS 10 0.0011
664 ORAL CANDIDIASIS 14 0.0011
665 REBOUND EFFECT 12 0.0011
666 CHOLECYSTITIS ACUTE 6 0.0011
667 HYPOPHAGIA 27 0.0011
668 HEPATITIS 27 0.0011
669 ACUTE MYOCARDIAL INFARCTION 31 0.0011
670 MENINGITIS 7 0.0010
671 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
672 HERPES ZOSTER 60 0.0010
673 ANAEMIA 199 0.0010
674 RENAL FAILURE CHRONIC 8 0.0010
675 BRONCHIECTASIS 7 0.0010
676 POST PROCEDURAL HAEMORRHAGE 12 0.0010
677 COLITIS 39 0.0010
678 THERAPY PARTIAL RESPONDER 16 0.0010
679 INTERSTITIAL LUNG DISEASE 49 0.0010
680 MYOCLONUS 12 0.0010
681 PREMATURE DELIVERY 16 0.0010
682 HAEMOPTYSIS 28 0.0010
683 HEARING IMPAIRED 6 0.0010
684 ANAPHYLACTIC REACTION 55 0.0010
685 PAPULE 7 0.0010
686 TOXIC SKIN ERUPTION 10 0.0010
687 BRONCHOSPASM 14 0.0010
688 CARDIOMEGALY 12 0.0010
689 HYPOKALAEMIA 45 0.0010
690 METASTASES TO LIVER 17 0.0010
691 TOXICITY TO VARIOUS AGENTS 162 0.0010
692 PNEUMONIA 310 0.0010
693 PERICARDITIS 16 0.0010
694 METASTASES TO LUNG 11 0.0010
695 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
696 SINUS BRADYCARDIA 9 0.0009
697 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
698 COMA 44 0.0009
699 DIABETIC KETOACIDOSIS 22 0.0009
700 PROCEDURAL COMPLICATION 7 0.0009
701 TUMOUR LYSIS SYNDROME 8 0.0009
702 MELAENA 20 0.0009
703 CARDIAC FAILURE 72 0.0009
704 OFF LABEL USE 779 0.0009
705 UVEITIS 12 0.0009
706 PNEUMOTHORAX 14 0.0009
707 BLOOD ALBUMIN DECREASED 7 0.0009
708 DRUG INTOLERANCE 85 0.0009
709 CONVULSION 50 0.0009
710 NEPHROPATHY 8 0.0009
711 FLANK PAIN 8 0.0009
712 SINUS TACHYCARDIA 12 0.0008
713 HEMIPLEGIA 7 0.0008
714 PNEUMONIA ASPIRATION 21 0.0008
715 PARALYSIS 12 0.0008
716 EJECTION FRACTION DECREASED 13 0.0008
717 CELLULITIS 42 0.0008
718 OESOPHAGITIS 9 0.0008
719 ATRIAL FIBRILLATION 78 0.0008
720 PERITONITIS BACTERIAL 8 0.0008
721 PURPURA 7 0.0008
722 HYPOTHERMIA 8 0.0008
723 DIABETES MELLITUS 60 0.0008
724 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
725 JAUNDICE 21 0.0008
726 HELICOBACTER INFECTION 8 0.0008
727 ELECTROLYTE IMBALANCE 9 0.0008
728 BLOOD PRESSURE DECREASED 51 0.0008
729 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
730 PULMONARY CONGESTION 10 0.0008
731 GASTROENTERITIS 11 0.0008
732 ARTERIOSCLEROSIS 7 0.0007
733 EOSINOPHILIA 13 0.0007
734 CARDIO-RESPIRATORY ARREST 31 0.0007
735 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
736 HAEMATOMA 19 0.0007
737 HICCUPS 6 0.0007
738 EMBOLISM 6 0.0007
739 HAEMATEMESIS 18 0.0007
740 MITRAL VALVE INCOMPETENCE 8 0.0007
741 GASTROINTESTINAL HAEMORRHAGE 59 0.0007
742 RESPIRATORY DISORDER 21 0.0007
743 MYDRIASIS 9 0.0007
744 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
745 SUBDURAL HAEMATOMA 10 0.0007
746 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
747 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
748 HYPOCALCAEMIA 13 0.0007
749 RENAL DISORDER 32 0.0007
750 DISEASE PROGRESSION 81 0.0007
751 GASTRITIS 18 0.0007
752 LACTIC ACIDOSIS 22 0.0007
753 DYSURIA 25 0.0007
754 TEMPERATURE INTOLERANCE 7 0.0007
755 BLOOD POTASSIUM INCREASED 11 0.0007
756 HEPATIC ENZYME INCREASED 46 0.0007
757 TOOTH DISORDER 15 0.0007
758 CARDIOTOXICITY 6 0.0007
759 BONE DENSITY DECREASED 21 0.0007
760 OSTEOMYELITIS 12 0.0007
761 ADRENAL INSUFFICIENCY 8 0.0007
762 SKIN CANCER 14 0.0006
763 ERYTHEMA MULTIFORME 6 0.0006
764 BODY TEMPERATURE INCREASED 13 0.0006
765 SLEEP APNOEA SYNDROME 12 0.0006
766 NEUROTOXICITY 11 0.0006
767 ABSCESS 10 0.0006
768 NEOPLASM 7 0.0006
769 DEHYDRATION 81 0.0006
770 DRUG INTERACTION 96 0.0006
771 HYPONATRAEMIA 34 0.0006
772 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
773 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
774 GASTROINTESTINAL DISORDER 53 0.0006
775 OEDEMA PERIPHERAL 72 0.0006
776 POLYNEUROPATHY 7 0.0006
777 THYROID CANCER 7 0.0006
778 CARDIAC FAILURE CONGESTIVE 46 0.0006
779 RENAL INJURY 17 0.0006
780 ABDOMINAL PAIN 133 0.0006
781 VIRAL INFECTION 19 0.0006
782 DEEP VEIN THROMBOSIS 37 0.0006
783 SMALL INTESTINAL OBSTRUCTION 7 0.0006
784 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
785 APHASIA 17 0.0006
786 METASTASES TO BONE 9 0.0005
787 OSTEONECROSIS 18 0.0005
788 ASPIRATION 6 0.0005
789 CARDIOMYOPATHY 8 0.0005
790 CYSTITIS 17 0.0005
791 CORONARY ARTERY DISEASE 16 0.0005
792 GASTRIC ULCER 10 0.0005
793 INFLAMMATION 27 0.0005
794 DELIRIUM 18 0.0005
795 LYMPHOMA 8 0.0005
796 DIARRHOEA 331 0.0005
797 MENORRHAGIA 10 0.0005
798 CYANOSIS 8 0.0005
799 RESPIRATORY ARREST 14 0.0005
800 INTENTIONAL PRODUCT USE ISSUE 44 0.0005
801 COVID-19 86 0.0005
802 RED BLOOD CELL COUNT DECREASED 14 0.0005
803 LIVER INJURY 12 0.0005
804 IMPAIRED HEALING 16 0.0005
805 DRUG INEFFECTIVE 642 0.0005
806 AGRANULOCYTOSIS 9 0.0005
807 ACNE 36 0.0005
808 FACE OEDEMA 8 0.0005
809 PULMONARY MASS 7 0.0005
810 DYSKINESIA 19 0.0005
811 ANOREXIA 6 0.0005
812 NEOPLASM MALIGNANT 31 0.0005
813 RESPIRATORY TRACT INFECTION 12 0.0005
814 SEIZURE 53 0.0005
815 PHARYNGEAL OEDEMA 7 0.0005
816 HAEMORRHAGE 47 0.0004
817 ISCHAEMIC STROKE 8 0.0004
818 TREATMENT NONCOMPLIANCE 24 0.0004
819 PANCREATITIS 23 0.0004
820 HEPATIC STEATOSIS 8 0.0004
821 EPILEPSY 13 0.0004
822 NERVOUS SYSTEM DISORDER 13 0.0004
823 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
824 METRORRHAGIA 7 0.0004
825 TREMOR 68 0.0004
826 CONFUSIONAL STATE 66 0.0004
827 LABORATORY TEST ABNORMAL 12 0.0004
828 INFLUENZA 45 0.0004
829 ABDOMINAL PAIN LOWER 10 0.0004
830 NECK PAIN 22 0.0004
831 DRUG EFFECT INCOMPLETE 14 0.0004
832 PULMONARY HYPERTENSION 8 0.0004
833 COLITIS ULCERATIVE 17 0.0004
834 ARRHYTHMIA 18 0.0004
835 RASH ERYTHEMATOUS 18 0.0004
836 VOMITING 177 0.0004
837 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
838 LIVER FUNCTION TEST INCREASED 8 0.0004
839 CHOLELITHIASIS 12 0.0004
840 MEDICATION ERROR 20 0.0004
841 CHRONIC KIDNEY DISEASE 27 0.0004
842 CARDIOVASCULAR DISORDER 9 0.0004
843 DRUG-INDUCED LIVER INJURY 11 0.0004
844 THROMBOSIS 28 0.0003
845 GENERAL PHYSICAL HEALTH DETERIORATION 40 0.0003
846 INTESTINAL OBSTRUCTION 13 0.0003
847 DECREASED APPETITE 80 0.0003
848 HEART RATE INCREASED 34 0.0003
849 AGITATION 25 0.0003
850 EXPOSURE DURING PREGNANCY 21 0.0003
851 RASH 147 0.0003
852 DYSPHAGIA 32 0.0003
853 BLOOD PRESSURE FLUCTUATION 8 0.0003
854 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
855 GASTROENTERITIS VIRAL 6 0.0003
856 PREMATURE BABY 10 0.0003
857 WEIGHT DECREASED 92 0.0003
858 NEUROPATHY PERIPHERAL 31 0.0003
859 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
860 HEPATIC CIRRHOSIS 6 0.0003
861 FLUID RETENTION 16 0.0003
862 ANGINA PECTORIS 9 0.0003
863 ORAL PAIN 7 0.0003
864 CONDITION AGGRAVATED 95 0.0003
865 UNRESPONSIVE TO STIMULI 8 0.0003
866 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
867 EAR PAIN 6 0.0003
868 HAEMORRHOIDS 6 0.0003
869 URTICARIA 51 0.0003
870 DYSPNOEA 171 0.0003
871 PULMONARY EMBOLISM 28 0.0003
872 PRODUCT PRESCRIBING ERROR 7 0.0003
873 PRODUCTIVE COUGH 14 0.0003
874 PRODUCT USE ISSUE 55 0.0003
875 COUGH 81 0.0003
876 MYALGIA 49 0.0003
877 CHEST DISCOMFORT 29 0.0003
878 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
879 DISORIENTATION 11 0.0003
880 NAUSEA 216 0.0003
881 SKIN ULCER 7 0.0003
882 RASH GENERALISED 7 0.0003
883 BLINDNESS 11 0.0003
884 DIPLOPIA 7 0.0003
885 ARTHRALGIA 109 0.0003
886 DRUG ADMINISTRATION ERROR 8 0.0003
887 PALLOR 7 0.0003
888 HEART RATE DECREASED 9 0.0003
889 BONE PAIN 15 0.0003
890 RECTAL HAEMORRHAGE 11 0.0003
891 EPISTAXIS 19 0.0003
892 PAIN IN JAW 7 0.0002
893 BRONCHITIS 18 0.0002
894 URINARY RETENTION 8 0.0002
895 PSYCHOTIC DISORDER 7 0.0002
896 HYPOTHYROIDISM 7 0.0002
897 ERYTHEMA 45 0.0002
898 MYOCARDIAL INFARCTION 38 0.0002
899 DIVERTICULITIS 6 0.0002
900 BLOOD PRESSURE INCREASED 33 0.0002
901 RHABDOMYOLYSIS 9 0.0002
902 CHEST PAIN 39 0.0002
903 ASTHENIA 78 0.0002
904 MENTAL DISORDER 9 0.0002
905 LOSS OF CONSCIOUSNESS 26 0.0002
906 WHEEZING 12 0.0002
907 HAEMATOCHEZIA 11 0.0002
908 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
909 SINUSITIS 20 0.0002
910 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
911 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
912 HEADACHE 122 0.0002
913 HYPERSENSITIVITY 36 0.0002
914 RHEUMATOID ARTHRITIS 22 0.0002
915 ALOPECIA 38 0.0002
916 UNDERDOSE 14 0.0002
917 DRUG EFFECT DECREASED 10 0.0002
918 UNEVALUABLE EVENT 14 0.0002
919 VAGINAL HAEMORRHAGE 8 0.0002
920 OROPHARYNGEAL PAIN 17 0.0002
921 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
922 COGNITIVE DISORDER 8 0.0002
923 ABDOMINAL PAIN UPPER 35 0.0002
924 VISUAL IMPAIRMENT 21 0.0002
925 DISTURBANCE IN ATTENTION 9 0.0002
926 RASH PRURITIC 9 0.0002
927 DEATH 143 0.0002
928 WEIGHT INCREASED 37 0.0002
929 HYPOGLYCAEMIA 8 0.0002
930 ABDOMINAL DISTENSION 17 0.0002
931 BLISTER 9 0.0002
932 MUSCULAR WEAKNESS 18 0.0002
933 ANGIOEDEMA 7 0.0002
934 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
935 LETHARGY 9 0.0002
936 SOMNOLENCE 31 0.0002
937 MUSCULOSKELETAL PAIN 8 0.0002
938 SPEECH DISORDER 8 0.0002
939 ABORTION SPONTANEOUS 6 0.0001
940 ADVERSE DRUG REACTION 13 0.0001
941 MALAISE 62 0.0001
942 DYSPHONIA 8 0.0001
943 PAIN 84 0.0001
944 NASAL CONGESTION 8 0.0001
945 BACK PAIN 31 0.0001
946 VISION BLURRED 18 0.0001
947 OVERDOSE 28 0.0001
948 PAIN IN EXTREMITY 38 0.0001
949 SWELLING 12 0.0001
950 BLOOD GLUCOSE INCREASED 24 0.0001
951 ARTHRITIS 10 0.0001
952 BLOOD GLUCOSE DECREASED 6 0.0001
953 PRURITUS 46 0.0001
954 HALLUCINATION 9 0.0001
955 CONSTIPATION 26 0.0001
956 NO ADVERSE EVENT 21 0.0001
957 GAIT DISTURBANCE 22 0.0001
958 INJURY 8 0.0001
959 INSOMNIA 30 0.0001
960 PRODUCT QUALITY ISSUE 15 0.0001
961 RHINORRHOEA 7 0.0001
962 PRODUCT STORAGE ERROR 9 0.0001
963 HYPOAESTHESIA 15 0.0001
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
965 ASTHMA 11 0.0001
966 PALPITATIONS 11 0.0001
967 BALANCE DISORDER 8 0.0001
968 ABDOMINAL DISCOMFORT 15 0.0001
969 FATIGUE 68 0.0001
970 ADVERSE EVENT 8 0.0001
971 HYPERHIDROSIS 11 0.0001
972 INCORRECT DOSE ADMINISTERED 19 0.0001
973 CONTUSION 8 0.0001
974 DYSPEPSIA 8 0.0001
975 FLUSHING 8 0.0001
976 ANXIETY 22 0.0001
977 JOINT SWELLING 9 0.0001
978 COMPLETED SUICIDE 6 0.0001
979 PERIPHERAL SWELLING 11 0.0001
980 NASOPHARYNGITIS 13 0.0001
981 SYNCOPE 7 0.0001
982 FALL 23 0.0001
983 HOSPITALISATION 10 0.0001
984 CARDIAC DISORDER 6 0.0001
985 DIZZINESS 30 0.0001
986 MUSCLE SPASMS 11 0.0001
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
988 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
989 DEPRESSION 12 0.0001
990 MEMORY IMPAIRMENT 7 0.0001
991 PARAESTHESIA 7 0.0000